Details of the Drug Reposition

General Information of This Drug (ID: DM9MKQ5)

Drug Name	Hu3F8 mAb DM9MKQ5

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)

2 Phase 2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Osteosarcoma	DISLQ7E2	2B51	Phase 2	[1]
Neuroblastoma	DISVZBI4	2D11.2	Phase 2	[2]
------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT02502786) Humanized Monoclonal Antibody 3F8 (Hu3F8) With Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) in the Treatment of Recurrent Osteosarcoma.
2	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)